Home Investors  >  Additional Resources  >  Tear Sheet

Tear Sheet

Corporate Profile

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 35,000 products in nearly every therapeutic area. 200 million people around the world take a Teva medicine every day, served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

Investor Relations
E-mail: TevaIR@tevapharm.com

SEC Filings

Date Filing Type Filing Description Download / View

Financial Reports

Corporate Officers

Kåre Schultz
President and CEO

Richard Daniell
Executive Vice President, European Commercial

Sven Dethlefs
Executive Vice President, Global Marketing & Portfolio and International Markets Commercial 

Eric Drapé
Executive Vice President, Global Operations

Dr. Hafrun Fridriksdottir
Executive Vice President, Global R&D

Eli Kalif
Executive Vice President and Chief Financial Officer (CFO)

Gianfranco Nazzi
Executive Vice President, Growth Markets Commercial

Brendan O'Grady
Executive Vice President, North America Commercial

Mark Sabag
Executive Vice President, Chief Human Resources Officer and Corp. Brand & Communications

David M. Stark
Executive Vice President, Chief Legal Officer

Nir Baron
Senior Vice President, Chief Internal Auditor

Lori Queisser
Senior Vice President & Global Compliance Officer